To gain a better understanding of systemic lupus erythematosus (SLE) in Puerto Ricans we studied the clinical and serologic manifestations in a cohort of 134 patients. The female to male ratio was 18: 1. Mean age at diagnosis was 32 12 y. The mean duration of disease and follow-up were 7.4 6.0 and 5.8 6.0 years respectively. Mortality was 3%. Photosensitivity (76.9%) and malar rash (71.9%) were the most common clinical manifestations. Arthritis was observed in 67.5% of patients. Anemia was seen in 67.2% of patients, but only 12.7% had autoimmune hemolytic anemia. Leukopenia (41.8%) and lymphopenia (64.9%) were also common. Serositis was observed in only 28%. Severe kidney damage such as nephrotic syndrome (14.2%) or renal failure (4%) was infrequent. Cardiovascular (12.7%) and neurologic (9.0%) manifestations were also uncommon. Antinuclear antibodies (ANA) were detected in 93.3%, anti-dsDNA antibodies in 54.5%, anti-Ro antibodies in 30.1% and anti-La antibodies in 14.2%. Low C3 and low C4 were observed in 38.3% and 35.7% respectively. This study suggests that Puerto Ricans with SLE present a mild form of disease predominantly manifested by cutaneous, musculoskeletal and hematologic involvement, but low prevalence of major organ damage and low mortality.
Mills JA . Systemic lupus erythematosus . N Engl J Med1994; 330: 1871—1879 .
3.
Cooper GS , Dooley MA , Treadwell EL et al. Hormonal, environmental, and infectious risk factor for developing systemic lupus erythematosus . Arthritis Rheum1998; 41: 1714—1724 .
4.
Lawrence RC , Hochberg MC , Kelsey JL et al. Estimates of prevalence of selected arthritic and musculoskeletal diseases in the United States . J Rheumatol1989; 16: 427—441 .
5.
Nossent JC . Systemic lupus erythematosus on the Caribbean Island of Curacao: An epidemiological investigation . Ann Rheum Dis1992; 51: 1197—1201 .
6.
Wilson WA , Hughes GR . Rheumatic diseases in Jamaica . Ann Rheum Dis1979; 38: 320—325 .
7.
Serdula MK , Rhoads GG . Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii . Arthritis Rheum1979; 22: 328—333 .
8.
Feng PH , Boey ML . Systemic lupus erythematosus in Chinese: the Singapore experience . Rheumatol Int1982; 2: 151—154 .
9.
Molina JF , Molina J , GarcíaC et al. Ethnic differences in the clinical expression of systemic lupus erythematosus: A comparative study between African-American and Latin American . Lupus1997; 6: 63—67 .
10.
Reveille JD , Moulds JM , Ahm C et al. Systemic lupus erythematosus in three ethnic groups: The effect of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset . Arthritis Rheum1998; 41: 1161—1172 .
11.
Rihner M , McGrath H . Fluorescent light photosensitivity in patients with systemic lupus erythematosus . Arthritis Rheum1992; 35: 949—952 .
12.
Siegel M , Lee SL . The epidemiology of systemic lupus erythematosus . Semin Arthritis Rheum1973; 3: 1—54 .
13.
Siegel M , Gwon N , Lee SL et al. Survivorship in systemic lupus erythematosus: relationship to race and pregnancy . Arthritis Rheum1969; 12: 117—125 .
14.
Tan EM , Cohen AS , Gries JF et al. Special article: the 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271—1277 .
15.
Cervera R , Khamashta MA , Font J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients . Medicine1993; 72: 113—124 .
16.
Pollak VE , Kant KS . Systemic lupus erythematosus and the kidney. In: Lahita RG (ed). Systemic lupus erythematosus. New York: John Wiley & Sons , 1987.
17.
Alarcón-Segovia D , Pérez-Vázquez ME , Villa AR et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus . Semin Arthritis Rheum1992; 21: 275—286 .
18.
Rosner B . Interval Estimates for Binomial Proportions3rd Edition. Fundamentals of Biostatistics. Duxbury Press, CA1990: 318—397.
19.
Statistical Package for Social Sciences . Crosstabulation and Measure of Association Release 6.0 SPSS for Windows Base System User Guide1990.
20.
Statistical Software for Exact Nonparametric Inference for Windows, CYTEL Software Co.1995, Second Edition Chapter 14 & 15; 441—558.
21.
Pistiner M , Wallace DJ , Nessin S , Metzger AL . Lupus erythematosus in the 1980s: a survey of 570 patients . Semin Arthritis Rheum1991; 21: 55—64 .
22.
Blanco FJ , De la Mata J , Gómez-Reino JJ et al. Manifestaciones clínicas y serológicas de 307 pacientes españoles con lupus eritematoso sistémico. Comparación con otros grupos étnicos . Rev Clin Exp1995; 195: 534—540 .
23.
Hochberg MC , Boyd RE , Ahearn JM et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets . Medicine1985; 64: 285—295 .
24.
Massardo L , Martínez ME , Jacobelli S et al. Survival of Chilean patients with systemic lupus erythematosus . Semin Arthritis Rheum1994; 24: 1—11 .
25.
Wysenbeek AJ , Block DA , Fries JF . Prevalence and expression of photosensitivity in systemic lupus erythematosus . Ann Rheum Dis1989; 48: 461—463 .
26.
Kind P , Lehmann P , Plewig G . Phototesting in lupus erythematosus . J Invest Dermatol1993; 100: 53S–57S .
27.
Villarreal GM , Drenkard C , Villa AR et al. Prevalence of 13 autoantibodies and of 16=6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity . Lupus1997; 6: 425—435 .
28.
Isenberg DA , Garton M , Reichlin MW , Reichlin M . Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients . Br J Rheumatol1997; 36: 229—233 .
29.
Steinman CR . Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis . Am J Med1979; 67: 429—435 .
30.
Mond CB , Peterson MG , Rothfield NF . Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients . Arthritis Rheum1989; 32: 202—204 .
31.
Gómez J , Palazón D , Ortega G et al. Infections and systemic lupus erythematosus. Analysis of risk factors and prognosis. A prospective study (1979—1988) . Rev Clin Esp1991; 188: 72—75 .
32.
Petri M , Genovese M . Incidence and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort . J Rheumatol1992; 19: 1559—1565 .
33.
Pryor BD , Bologna SG , Kahl LE . Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus . Arthritis Rheum1996; 39: 1475—1482 .
34.
Hellmann DB , Petri M , Whiting-O'Keefe Q . Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms . Medicine1987; 66: 341—348 .
35.
Abu-Shakra M , Urowitz MB , Gladman DD , Gough J . Mortality studies in systemic lupus erythematosus from a single center. I. Causes of death . J Rheumatol1995; 22: 1259—1264 .
36.
Kaufman LD , Gomez-Reino JJ , Heinicke MH , Gorevic PD . Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature . Semin Arthritis Rheum1989; 18: 189—197 .
37.
Ward MM , Pyun E , Studenski S . Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes . Arthritis Rheum1995; 38: 274—283 .
38.
Karlson EW , Daltroy LH , Lew RA et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus . Arthritis Rheum1995; 38: 267—273 .
39.
Alarcón GS , Roseman J , Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups. II. Features predictive of disease activity early in its course . Arthritis Rheum1998; 41: 1173—1180 .
40.
Vilá LM , Reyes ML , Vilá S , Rodríguez L . Impact of socioeconomic status on clinical outcome in Puerto Ricans with systemic lupus erythematosus . Arthritis Rheum1996; 39 (suppl): R17-R17 (abstract P4).
41.
Lawrence JS , Martins CL , Drake GL . A family survey of lupus erythematosus: 1. Heritability . J Rheumatol1987; 14: 913—921 .
42.
Fronek Z , Timmerman LA , Alper CA et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus . Arthritis Rheum1990; 33: 1542—1553 .
43.
Freedman BI , Spray BJ , Heise ER et al. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis . Am J Kidney Dis1993; 21: 378—382 .
44.
Granados J , Vargas Alarcón G , Drenkard C et al. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE) . Lupus1997; 6: 57—62 .
